Liver function and drug processing: new study explores BI 1015550
NCT ID NCT05661344
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looked at how the drug BI 1015550 is processed in people with mild or moderate liver problems compared to those with healthy livers. Twenty-eight adults took a single dose of the drug, and researchers measured its levels in the blood over time. The goal was to understand if liver impairment changes how the drug behaves, which helps doctors decide on safe dosing. No treatment was given for any disease; this was purely to gather safety and processing information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, 24105, Germany
Conditions
Explore the condition pages connected to this study.